natgillin/translations-raw huggingface dataset:
6 • Bland medicinen ved langsomt at skrue cylinderampullen ned i urets retning (se figuren “Før”), indtil du hører og mærker et “klik”, og du ikke længere kan dreje cylinderampullen (se figuren “Efter”). 
6 • To mix the medicine, slowly screw down the cartridge in a clockwise direction (See “Before” figure) until you hear and feel a “click” and the cartridge will no longer turn (See “After” figure).
Der er rapporteret om hypokalcæmi, en almindelig klinisk manifestation ved hypoparatyroidisme, i kliniske studier med Natpar. 
Hypocalcaemia, a common clinical manifestation of hypoparathyroidism, was reported in clinical trials with Natpar.
9 • Med kanylehætten stadig pegende lige op, skal du banke på cylinderampullen med spidsen af din negl 3 til 5 gange, eller indtil alle større luftbobler stiger til vejrs (se figur J). 
9 • With the needle cap still pointing straight up, tap the cartridge with the tip of your fingernail 3 to 5 times, or until any large air bubbles move to the top (See Figure J).
Du kan smitte andre eller selv få en alvorlig infektion ved at dele din pen eller dine penkanyler. 
Sharing your pen or pen needles may give yourself or others a serious infection.
• Saml pennen og andre nødvendige redskaber som vist i figuren nedenfor, 
• Gather your pen and other supplies needed as shown in the figure below and set them on a clean, flat surface.
Symptomer, der muligvis er forbundet med hypokalcæmi, som sås i de kliniske studier. 
Signs and symptoms potentially associated with hypocalcaemia that were observed in the clinical trials.
Hos patienter, der samtidigt tager hjerteglykosider (f.eks. digoxin eller digitoxin), skal serumcalcium og hjerteglykosidniveauet monitoreres, og patienterne skal overvåges for symptomer på digitalis-forgiftning (se pkt. 
In patients using Natpar concomitantly with cardiac glycosides (such as digoxin or digitoxin), monitor serum calcium and cardiac glycoside levels and patients for signs and symptoms of digitalis toxicity (see section 4.5).
• Tag hætten af pennen. 
• Remove the pen cap from your pen.
• Skriv dags dato på linjen “Blandet den”. 
• Write today's date in the space next to “Date Mixed”.
Hyperkalcæmi og hypokalcæmi var almindeligt forekommende bivirkninger under dosistitreringen. 
Hypercalcaemia and hypocalcaemia were commonly encountered during the dose titration period.
• Tryk kanylen helt ind i hætten. 
• Press the needle all the way into the cap.
Pakningsstørrelse: Æske med 2 fyldte penne. 
Pack size: Carton containing 2 pre-filled pens.
Målet med Natpar-behandling er at opnå serumcalcium 2,0-2,25 mmol/l før administration og < 2,55 mmol/l 8-12 timer efter administration. 
The aim of treatment with Natpar is to achieve a pre-dose serum calcium concentration of 2.0-2.25 mmol/L and an 8-12 hour post-dose serum calcium concentration <2.55 mmol/L.
Den maksimale plasmakoncentration (gennemsnitlig Tmax) af Natpar opnås inden for 5-30 minutter, og en efterfølgende ofte lavere maksimal plasmakoncentration opnås inden for 1-2 timer. 
Peak plasma concentrations (mean Tmax) of Natpar occur within 5 to 30 minutes and a second usually smaller peak at 1 to 2 hours.
Natpar 100 mikrogram 
Natpar 100 micrograms
8 • Tryk på den gule knap, indtil den blå knap kommer ud (se figur I). 
8 • Press the yellow button until the blue button pops out (See Figure I).
12 • Træk den blå kanylebeskyttelse af og kassér den (se figur S). 
12 • Pull the blue needle guard straight off and discard it (See Figure S).
• Skru kanylen lige på cylinderampullen (se figuren “Før”), indtil den sidder stramt på (se figuren “Efter”). 
• Screw the needle straight onto the cartridge (See “Before” figure) until it is tightly attached (See “After” figure).
Virkning på mineralomsætningen 
Effect on mineral metabolism
• krampeanfald pga. et nedsat kalciumniveau i dit blod 
• seizures (fits) due to low levels of calcium in your blood
• Hvis dosistælleren viser “0” (ingen doser tilbage), eller datoen “Kasseres den” er overskredet (se datoetiket), skal du kassere den brugte pen i beholderen til skarpe genstande (se figur Z) som anvist i trin 17: “Kassér dine brugte kanyler og penne.” 
• If the dose counter shows “0” (no doses remaining) or the “Discard On” date has passed (see Medicine Tracker), discard the used pen in the sharps container (See Figure Z) as instructed in Step 17: “Discard your used needles and pens.”
Fortsæt med at trykke på den blå knap indtil du høre, før du r et ”hårdt” klik og den blå knap forbliver inde. 
Continue to push the blue button until you hear a ‘hard' click and the blue button stays in. Make sure that the blue button stays down.
Dette gælder f.eks. - digoxin, også kendt som digitalis, en type hjertemedicin - medicin til behandling af knogleskørhed, såkaldte bisfosfonater, f.eks. alendronsyre - medicin, der kan påvirke kalciumniveauet i blodet, såsom lithium eller visse lægemidler, der bruges til at øge mængden af urin (diuretika). 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including: - digoxin, also known as digitalis, a heart medicine - medicines used to treat osteoporosis, called bisphosphonates, such as alendronic acid - medicines that can affect calcium levels in your blood such as lithium or some medicines used to increase the amount of urine (diuretics).
Den gennemsnitlige maksimale koncentration (Cmax) af PTH efter 100 mikrogram parathyroideahormon (rDNA) var ca. 23 % højere hos forsøgspersoner med let til moderat nedsat nyrefunktion (CLcr 30-80 ml/min) end hos forsøgspersoner med normal nyrefunktion. 
The mean maximum concentration (Cmax) of PTH following 100 micrograms parathyroid hormone (rDNA) in subjects with mild-to-moderate renal impairment (CLcr 30 to 80 mL/min) was approximately 23% higher than that observed in subjects with normal renal function.
Knogler, led, muskler og bindevæv artralgi*, muskelspasmer muskelsammentrækninger , muskuloskeletale smerter 
Musculoskeletal and connective tissue disorders arthralgia*, muscle spasms muscle twitching musculoskeletal pain myalgia
Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager Natpar. 
Talk to your doctor, pharmacist or nurse before using Natpar.
2,25 mmol/l eller derunder og over 2 mmol/l 
Less than or equal to 2.25 mmol/L and above 2 mmol/L
• kvalme og opkastning* 
• nausea and vomiting*
• muskelsammentrækninger eller kramper 
• muscle twitching or cramping
I de kliniske studier blev disse bivirkninger, der generelt var lette til moderate og forbigående, håndteret ved dosisjustering af Natpar, calcium og/eller aktivt D-vitamin (se pkt. 
In the clinical studies, these reactions were generally mild to moderate in severity and transient, and were managed with adjustments of Natpar, calcium and/or active vitamin D doses (see sections 4.4 and 5.1).
Figur A 
Figure A
Natpar bruges som erstatning for et hormon hos voksne med nedsat funktion af biskjoldbruskkirtlerne, såkaldt hypoparatyroidisme. 
Natpar is a hormone replacement for adults with under-active parathyroid glands, a condition known as ‘hypoparathyroidism'.
Natpar fås i penne med 4 forskellige styrker (hver fyldt pen indeholder 14 doser): 
It is available in 4 different strengths of pen (each pre-filled pen contains 14 doses): Natpar 25 micrograms
• Hvis det er første gang, du bruger pennen, skal du gå til “Klargøring og blanding af ny pen (afsnit B). 
• If you are using the pen for the first time, continue to “New Pen Setup &
I den forbindelse vil du få taget blodprøver og urinprøver for at få målt mængden af kalcium i blodet og urinen. 
This will be done using tests to measure the level of calcium in your blood or urine.
• Du må ikke bruge lægemidlet, hvis det er uklart, er farvet eller indeholder synlige partikler. 
• Do not use your medicine if it is cloudy, if it is coloured, or if it contains visible particles.
† Disse bivirkninger kan skyldes lave kalciumniveauer i blodet. 
These side effects may be related to low level of calcium in your blood.
Tag altid lægemidlet nøjagtigt efter lægens anvisning. 
Always use this medicine exactly as your doctor or pharmacist has told you.
Mål serumcalcium før administration indenfor 2-5 dage. 
Measure pre-dose serum calcium concentration within 2 to 5 days.
Natpar 100 mikrogram/dosis Blå etiket. 
Natpar 100 micrograms/dose Blue pen label.
Undersøgelser positiv test for antiparathyroideahormon (PTH)-antistoffer, nedsat 25-hydroxykolekalciferol i blodet 
Investigations anti-PTH antibody positive, blood 25-hydroxycholecalcif erol decreased vitamin D decreased
Før medicinen blandes 
Before mixing
• Opbevar din pen med den penhætten påsat. 
• Store your pen with the pen cap on.
Udskillelse af calcium i urinen 
Urinary calcium excretion
• nedsat indhold af D-vitamin og magnesium i blodprøver 
• in blood tests, your doctor may see decreased levels of vitamin D and magnesium
14 • Træk langsomt kanylen lige ud af låret (se figur U). 
14 • Slowly pull the needle straight out of your thigh (See Figure U).
Vand til injektionsvæsker 
Metacresol Water for injections
Behandling med Natpar nedsætter urinudskillelsen af calcium med henholdsvis 13 og 23 % ved doser på 50 og 100 mikrogram, idet der ses nadir efter 3-6 timer. 
Treatment with Natpar produces a decrease in urinary calcium excretion by 13 and 23% (50 and 100 microgram dose, respectively) to a nadir in the 3 to 6 hour time point, which returns to pre-dosing levels by 16 to 24 hours.
Luftveje, thorax og hoste mediastinum Mave-tarm-kanalen diarré* 
Respiratory, thoracic and mediastinal cough disorders Gastrointestinal disorders diarrhoea*
Af hensyn til miljøet må du ikke smide medicinrester i skraldespanden. 
Do not throw away any medicines via household waste.
13 • Stik forsigtigt kanylen helt ind i dit lår (se figur T). 
13 • Gently insert the needle fully into your thigh (See Figure T).
Natpar gives som subkutan injektion (under huden) hver dag. 
Natpar is given as a subcutaneous (under the skin) injection every day, using a pen to help you inject your medicine.
• prikkende fornemmelse og følelsesløshed i huden 
• tingling and numbness of the skin
6.1 - der gennemgår eller tidligere har gennemgået strålebehandling af skelettet - der har maligne sygdomme i skelettet eller knoglemetastaser - der har øget risiko for osteosarkom ved baseline, f.eks. Pagets knoglesygdom eller arvelige sygdomme - der har uforklarligt forhøjet knogle-specifik basisk fosfatase - der har pseudohypoparatyroidisme. 
Natpar is contraindicated in patients: - with hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - who are receiving or who have previously received radiation therapy to the skeleton - with skeletal malignancies or bone metastases - who are at increased baseline risk for osteosarcoma such as patients with Paget's disease of bone or hereditary disorders - with unexplained elevations of bone-specific alkaline phosphatase - with pseudohypoparathyroidism.
Der vil være et ”blødt” klik, før du hører det ”hårde” klik, når du trykker på den blå knap. 
There is a ‘soft' click when you push the blue button before you hear the ‘hard' click, which indicates that you have begun to deliver the medicine.
Hold den rekonstituerede fyldte pen tæt tillukket for at beskytte mod lys. 
Keep the reconstituted pre-filled pen tightly closed in order to protect from light.
Hvis væsken er uklar, farvet eller indeholder synlige partikler, må du ikke bruge din medicin. 
If the liquid is cloudy, is coloured, or contains visible particles, do not use your medicine.
Du må ikke genbruge beholderen til skarpe genstande. 
Do not recycle your used sharps disposal container.
• Natriumchlorid 
• sodium chloride
Vigtigt: Hvis du har spørgsmål vedrørende opbevaring af din pen, skal du ringe til Shire på +44 (0)800 055 6614 for at få hjælp. 
Important: If you have questions about storage of your pen, call Shire at +44 (0)800 055 6614 for help.
Figur H 
Figure H
Hvis albumin-korrigeret serumcalcium efter administration overstiger den øvre normalgrænse, og alt tilskud af aktivt D-vitamin og oralt calcium er seponeret, eller der ses symptomer på hyperkalcæmi, skal Natpar-dosis reduceres uanset dosisniveau (se pkt. 
At any dose level of Natpar, if post-dose albumin-corrected serum calcium exceeds the ULN and all active vitamin D and oral calcium have been withheld, or symptoms suggesting hypercalcaemia are present, the dose of Natpar should be reduced (see section 4.4).
Brug penkanyler (31G x 5 mm, 31G x 8 mm eller 32G x 4 mm). 
Use pen needles (31Gx5 mm, 31Gx8 mm, or 32Gx4 mm).
Figur Y 
Figure Y
15 • Sæt forsigtigt kanylehætten tilbage på kanylen ved at “skovle” kanylehætten op med den ene hånd (se figur V). 
15 • Carefully put the needle cap back on the pen needle by scooping the back of the needle using only one hand (See Figure V).
Medicinen skal blandes, før du bruger pennen første gang. 
Before the pen is used for the first time, the medicine has to be mixed.
• Opbevar den fyldte pen i den ydre karton for at beskytte mod lys. 
• Keep the pre-filled pen in the outer carton in order to protect from light.
Figur X 
Figure X
• Hvis væsken er uklar, er farvet eller indeholder synlige partikler, må du ikke bruge din medicin. 
• If the liquid is cloudy, is coloured, or contains visible particles, do not use your medicine.
Der foreligger ingen data for patienter med svært nedsat nyrefunktion. 
There are no data in patients with severe renal impairment.
69 % (58/84) af de patienter, der var randomiseret til Natpar, fik reduceret deres dosis af oralt calcium med ≥ 50 %, mens dette kun var tilfældet for 7,5 % (3/40) af de patienter, der var randomiseret til placebo. 
Sixty-nine percent (58/84) of subjects randomised to Natpar showed a reduction in oral calcium of ≥50% compared to 7.5% (3/40) of subjects randomised to placebo.
Lær Natpar fyldt pen at kende Natpar fyldt pen 
Get to know the Natpar Pre-filled Pen Natpar Pre-filled Pen
Figur Q 
Figure Q
I punkt 4 er der en liste over symptomer på for lavt kalciumniveau. 
For a list of symptoms of low calcium, see section 4.
Læs punkt 7, "Brugervejledning", i denne indlægsseddel, inden du bruger pennen. 
Instructions for use” in this leaflet before you use the pen.
Skal bruges sammen med pen-kanyler (31G x 5 mm, 31G x 8 mm eller 32G x 4 mm) 
Use with pen needles (31Gx5 mm, 31Gx8 mm, or 32Gx4 mm)
Her kan du se, hvordan du skal klargøre, injicere og opbevare Natpar fyldt pen. 
This guide is designed to help you prepare, inject, and store your Natpar Pre-filled Pen.
Serumcalcium før og i nogle tilfælde efter administration skal monitoreres under behandlingen med Natpar (se pkt. 
Pre-dose and in some cases post-dose serum calcium levels must be monitored during treatment with Natpar (see section 4.2).
Natpar 75 mikrogram 
Natpar 75 micrograms
Hvis en dosis glemmes, skal Natpar administreres, så snart det er praktisk muligt, og patienten skal tage yderligere tilskud af eksogent calcium og/eller aktivt D-vitamin alt efter symptomer på hypokalcæmi. 
In the case of a missed dose, Natpar must be administered as soon as reasonably feasible and additional exogenous sources of calcium and/or active vitamin D must be taken based on symptoms of hypocalcaemia.
Figur V 
Figure V
Hver fyldt pen med Natpar indeholder en cylinderampul med lægemidlet som et pulver sammen med en opløsningsvæske; dette blandes til en injektionsvæske, opløsning. 
What Natpar looks like and contents of the pack Each pre-filled pen of Natpar contains a cartridge with medicine as a powder together with a solvent to make a solution for injection.
Du har muligvis skruet den klare cylinderampul med medicin for hurtigt ned. 
You may have screwed down the clear medicine cartridge too quickly, wait 5 minutes for the foaming to subside.
Derefter kan det overvejes at genoptage behandlingen med Natpar, calcium og aktivt D-vitamin i lavere doser (se pkt. 
Then consider resuming Natpar, calcium and active vitamin D at lower doses (see sections 4.2 and 4.8).
Se figur X 
See Figure X
Hvis serumcalcium efter administration ligger over den øvre normalgrænse, skal tilskuddet af aktivt D-vitamin og calcium først reduceres og udviklingen overvåges. 
If post-dose serum calcium is >ULN, then first reduce active vitamin D and calcium supplements and monitor progress.
10 • Træk kanylehætten lige af og læg den til side (se figur Q). 
10 • Pull the needle cap straight off and set it aside (See Figure Q).
Parathyroideahormon (rDNA) må ikke anvendes, hvis den rekonstituerede injektionsvæske er uklar, farvet eller indeholder synlige partikler. 
After reconstitution, the liquid must be colourless and practically free of foreign particles; parathyroid hormone (rDNA) must not be used if the reconstituted solution is cloudy, coloured, or contains visible particles.
Nyrer og urinveje hyperkalciuri*, pollakisuri 
Renal and urinary disorders hypercalciuria pollakiuria
Ved hver injektion skal der bruges en ny, steril kanyle. 
A new sterile needle must be used for every injection.
3 • Tag penhætten af pennen (se figur M). 
3 • Remove the pen cap from your pen (See Figure M).
Forekomsten af hypokalcæmi kan minimeres ved at følge den anbefalede dosering, tage højde for monitoreringsdata og udspørge patienterne om alle symptomer på hypokalcæmi (se pkt. 
Hypocalcaemia may be minimised by following the recommended dosing, the monitoring information, and asking patients about any symptoms of hypocalcaemia (see sections 4.2 and 4.8).
Nervesystemet hovedpine* hypæstesi 
Nervous system disorders headache* hypoaesthesia paraesthesia somnolence*
• Ring til Shire på +44 (0)800 055 6614. 
• Call Shire at +44 (0)800 055 6614.
Immunsystemet 
Immune system dysorders
Figur C Datoetiket 
Figure C Medicine Tracker
Figur S 
Figure S
Figur O 
Figure O
6 • Fjern papirforseglingen fra den kanylehætten (se figur N). 
6 • Remove the paper tab back from the needle cap (See Figure N).
Brug ikke pennen, hvis injektionsvæsken er uklar, farvet eller indeholder synlige partikler. 
Do not use the pen if the solution is cloudy or coloured or if it contains visible particles.
Figur D 
Figure D
Det er påkrævet at monitorere for hypokalcæmi, hvis Natpar seponeres (se pkt. 
If Natpar is to be discontinued, monitoring for hypocalcaemia is necessary (see section 4.2).
Figur B 
Figure B
Figur Z 
Figure Z
4 • Tjek medicinen, inden du påsætter en ny kanyle. 
4 • Before attaching a new needle, check the medicine.
Figur I 
Figure I
Figur J 
Figure J
Ved midlertidig behandlingsafbrydelse eller permanent seponering af Natpar skal serumcalcium monitoreres, og tilskuddet af eksogent calcium og/eller aktivt D-vitamin skal om nødvendigt øges. 
Temporary or permanent discontinuation of Natpar must be accompanied by monitoring of serum calcium levels and increase of exogenous calcium and/or active vitamin D sources as necessary.
Figur T 
Figure T
Figur M 
Figure M
Der er ikke gennemført interaktionsstudier med hjerteglykosider og Natpar (se pkt. 
No drug-drug interaction study has been conducted with cardiac glycosides and Natpar (see section 4.4).
Figur F 
Figure F
Figur W 
Figure W
Natpar 50 mikrogram 
Natpar 50 micrograms
Figur P 
Figure P
Pakningsstørrelser og yderligere oplysninger 7. 
Contents of the pack and other information 7 Instructions for use
• Hold den rekonstituerede pen tæt tillukket for at beskytte mod lys. 
• Keep the mixed pen tightly closed in order to protect from light.
Natpar 25 mikrogram 
Natpar 25 micrograms
For at holde øje med, om dette sker, bør responsen på Natpar-administration i form af serumcalcium-niveauet monitoreres regelmæssigt, og takyfylaksi bør i givet fald overvejes. 
The response of serum calcium concentration to administration of Natpar should be monitored at intervals to detect this and the diagnosis of tachyphylaxis considered.
Hyperkalcæmi 
Hypercalcaemia
Figur G 
Figure G
Hvis du har taget for meget Natpar 
If you use more Natpar than you should
Der foreligger ingen data for patienter med svært nedsat leverfunktion (se pkt. 
There are no data available in patients with severe renal impairment (see section 4.4).
E. SÆRLIG FORPLIGTELSE TIL AT AFSLUTTE FORANSTALTNINGER EFTER UDSTEDELSE AF MARKEDSFØRINGSTILLADELSE TIL LÆGEMIDLER GODKENDT UNDER BETINGEDE OMSTÆNDIGHEDER 
E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES
Figur N 
Figure N
Figur R 
Figure R
Figur U 
Figure U
I leveren spaltes parathyroideahormon af cathepsiner. 
In the liver, parathyroid hormone is cleaved by cathepsins.
Ved midlertidig eller permanent seponering af Natpar skal serumcalcium monitoreres, og tilskuddet af eksogent calcium og/eller aktivt D-vitamin skal om nødvendigt justeres (se pkt. 
Temporary or permanent discontinuation of Natpar treatment must be accompanied by monitoring of serum calcium levels and adjustment, as necessary, of exogenous calcium and/or active vitamin D (see section 4.4).
Hvis en dosis glemmes 
Missed dose
Reducér 
Decrease
Start af behandling med Natpar 
Initiating Natpar
Figur K 
Figure K
Efter markedsføring er der rapporteret tilfælde af hypokalcæmi, der førte til slagtilfælde (se pkt. 
Cases of hypocalcaemia resulting in seizures have been reported post-marketing (see section 4.4).
Hjerte palpitationer* 
Cardiac disorders palpitations*
3 • Tag nålen og fjern papirforseglingen fra kanylehætten (se figur F). 
3 • Pick up the needle and peel the paper tab back from the needle cap (See Figure F).
øvre abdominalsmerter* 
abdominal pain upper*
Justér dernæst 
Adjust second
Figur E 
Figure E
Blodprøver og urinprøver 
Tests and checks
Du skal gemme pennen og ringe til Shire på +44 (0)800 055 6614 for at få en erstatning. 
You should save the pen and call Shire at +44 (0)800 055 6614 to discuss getting a replacement.
Ring til Shire på +44 (0)800 055 6614 for at få hjælp. 
Call Shire at +44 (0)800 055 6614 for help.
Patientens serumcalcium skal monitoreres ved behandling med ethvert lægemiddel, der påvirker serumcalcium (f.eks. lithium, thiazider). 
For any drug that affects serum calcium levels (e.g., lithium, thiazides), patients' serum calcium levels should be monitored.
Hver fyldt pen indeholder 700 mikrogram parathyroideahormon (rDNA). 
Each pre-filled pen contains 700 micrograms parathyroid hormone (rDNA).
Hver fyldt pen indeholder 1.050 mikrogram parathyroideahormon (rDNA). 
Each pre-filled pen contains 1050 micrograms parathyroid hormone (rDNA).
Studiet var et 24-ugers, randomiseret, dobbeltblindet, placebo-kontrolleret multicenterstudie. 
The objective of this trial was to maintain serum calcium with Natpar while reducing or replacing oral calcium and active vitamin D. The study was a 24-week, randomised, double-blind, placebo-controlled, multicentre trial.
Natpar 25 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 50 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 75 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 100 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Natpar 25 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 50 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 75 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 100 micrograms/dose powder and solvent for solution for injection in pre-filled pen
Hver fyldt pen indeholder 350 mikrogram parathyroideahormon (rDNA). 
Each pre-filled pen contains 350 micrograms parathyroid hormone (rDNA).
Den daglige dosis kan variere fra 25 til 100 mikrogram Natpar. 
People may need between 25 and100 micrograms of Natpar per day.
Virkning og anvendelse 2. 
What Natpar is and what it is used for 2.